RxDoctor Payments Data

John Anderson, DPM

Podiatrist · Alamogordo, NMNPI 1235101940

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (52.6%), royalties or licence payments and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 52.6% of the total. Reporting peaked in 2022 at $737,824 and has fallen 92.8% since, to $52,952 in 2025. Among podiatrist clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,386,611in general payments, 2019–2025

Across 122 payments — averaging $11,366 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$730K
  • Trilliant Surgical LLC.$456K
  • Vilex LLC$181K
  • Stryker$8K
  • Ortho Solutions Inc$8K
  • Organogenesis Inc.$2K
  • plus $947 from 9 others
$6,760in research payments, 2019–2025

Across 2 payments — averaging $3380.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vilex LLC$7K

What the payments were for

  • Royalty or licence$590,77043%
  • Consulting fees$54,5944%
  • Travel & lodging$5,4350%
  • Food & beverage$2,2640%
  • Education$4,0000%
  • Other$729,54853%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson2$729,548
Trilliant Surgical LLC.7$455,835
Vilex LLC48$181,454
Stryker(2 entities)19$8,386
Ortho Solutions Inc13$8,346
Organogenesis Inc.6$2,095
Smith+Nephew12$524
Encore Medical, LP2$164
Orthofix Medical, Inc.5$88
CPM Medical Consultants, LLC1$47
Integra Lifesciences Corporation2$39
DJO, LLC2$35
Amgen1$23
Abbott1$20
Stability Biologics, LLC1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,386,611 in reported general payments places this provider in the 95th percentile of 46 podiatrist providers in New Mexico.

See all podiatrist providers in New Mexico

Medicare billing

Part B allowed, 2024
$162,196
Medicare patients
170
Services billed
2,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$734
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$518
Pregabalin19$422
Gabapentin45$406
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$391
Ciprofloxacin Hcl28$369
Ondansetron Hcl26$285
Acetaminophen-CodeineAcetaminophen With Codeine16$230
Vitamin D2Ergocalciferol (Vitamin D2)12$174
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$145
Ciclopirox12$138
Tramadol Hcl15$102
Meloxicam23$82
Azithromycin18$78

Paid to pharmacies, not to this prescriber.

Other podiatrist in Alamogordo

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →